ARCHIVES

FDA Moves To Revoke Avastin’s Breast Cancer Accelerated Approval, Genentech Vows To Fight

This article is from The Cancer Letter archive.

Vol. 36 No. 46 | December 17, 2010

Download PDF Visit The Full Archive

Related Articles

NCI to Study Review Group’s report Urging Restructure of Prevention Programm

June 27, 1997

In Brief: Schilsky Named ASCO Chief Medical Officer

November 1, 2012

Research Contract Dollars Will Drop In 1980, But Will Increase Sharply for Some Programs

July 7, 1978

DCE Board Approves Recompetition Concepts

March 18, 1988

I-131 doses highest Near Nevada Test Site, Fallout Study Finds

November 17, 1989

Program Announcement listed.

July 25, 2003